Filing Details
- Accession Number:
- 0000932440-15-000125
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-02 11:00:15
- Reporting Period:
- 2015-04-01
- Filing Date:
- 2015-04-02
- Accepted Time:
- 2015-04-02 11:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1437786 | Immune Design Corp. | IMDZ | Pharmaceutical Preparations (2834) | 262007174 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1033508 | Jay Moorin | C/O Proquest Investments 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1225149 | Alain Schreiber | C/O Proquest Investments 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1431818 | Proquest Investments Iv, L.p. | 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No | |
| 1431819 | Proquest Associates Iv Llc | 2430 Vanderbilt Beach Road, #108 - 190 Naples FL 34109 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-04-01 | 14,600 | $25.51 | 2,399,440 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-01 | 39,819 | $26.55 | 2,359,621 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-04-01 | 8,035 | $27.07 | 2,351,586 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The securities are directly held by ProQuest Investments IV, L.P. and indirectly held by ProQuest Associates IV, LLC, the General Partner of ProQuest Investments IV, L.P. The individual managing members of ProQuest Associates IV, LLC are Jay Moorin and Alain Schreiber, M.D., each of whom may be deemed to have shared voting, investment and dispositive power with respect to these securities. Each individual managing member disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
- Constitutes the weighted average sale price for multiple transactions reported on this line having prices per share ranging from $25.00 to $25.98. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
- Constitutes the weighted average sale price for multiple transactions reported on this line having prices per share ranging from $26.00 to $26.99. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
- Constitutes the weighted average sale price for multiple transactions reported on this line having prices per share ranging from $27.00 to $27.57. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction.
Billionaire Hedge Funds
